• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

各种NONMEM估计方法的推导。

Derivation of various NONMEM estimation methods.

作者信息

Wang Yaning

机构信息

Food and Drug Administration, Office of Clinical Pharmacology, CDER, WO21 RM3662 HFD-880, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

出版信息

J Pharmacokinet Pharmacodyn. 2007 Oct;34(5):575-93. doi: 10.1007/s10928-007-9060-6. Epub 2007 Jul 10.

DOI:10.1007/s10928-007-9060-6
PMID:17620001
Abstract

Various estimation methods and the lack of a systematic derivation of the core objective function implemented in NONMEM for nonlinear mixed effect modeling has caused consistent confusion and inquiry among scientists who routinely use NONMEM for data analysis. This paper provides a detailed derivation of the objective functions for the most commonly used estimation methods in NONMEM, such as the Laplacian method, the first-order conditional estimation method (FOCE) with or without interaction, and the first-order method (FO). In addition, models with homogenous or heterogeneous residual error were used to demonstrate the relationship between the objective functions derived from two different types of approximation, namely Laplacian approximation of log-likelihood and linearized model approximation. The relationship between these estimation methods and those implemented in SAS and Splus is discussed.

摘要

用于非线性混合效应建模的各种估计方法以及NONMEM中实现的核心目标函数缺乏系统推导,这在经常使用NONMEM进行数据分析的科学家中引发了持续的困惑和疑问。本文详细推导了NONMEM中最常用估计方法的目标函数,如拉普拉斯方法、带或不带交互作用的一阶条件估计方法(FOCE)以及一阶方法(FO)。此外,使用具有同质或异质残差误差的模型来证明从两种不同类型近似推导的目标函数之间的关系,即对数似然的拉普拉斯近似和线性化模型近似。还讨论了这些估计方法与SAS和Splus中实现的方法之间的关系。

相似文献

1
Derivation of various NONMEM estimation methods.各种NONMEM估计方法的推导。
J Pharmacokinet Pharmacodyn. 2007 Oct;34(5):575-93. doi: 10.1007/s10928-007-9060-6. Epub 2007 Jul 10.
2
Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.参数和非参数总体方法:它们在分析临床数据集和两项蒙特卡罗模拟研究中的比较性能。
Clin Pharmacokinet. 2006;45(4):365-83. doi: 10.2165/00003088-200645040-00003.
3
Evaluation of the nonparametric estimation method in NONMEM VI.NONMEM VI中无参数估计方法的评估。
Eur J Pharm Sci. 2009 Apr 11;37(1):27-35. doi: 10.1016/j.ejps.2008.12.014. Epub 2008 Dec 30.
4
Assessment of actual significance levels for covariate effects in NONMEM.评估NONMEM中协变量效应的实际显著性水平。
J Pharmacokinet Pharmacodyn. 2001 Jun;28(3):231-52. doi: 10.1023/a:1011527125570.
5
Comparing the performance of first-order conditional estimation (FOCE) and different expectation-maximization (EM) methods in NONMEM: real data experience with complex nonlinear parent-metabolite pharmacokinetic model.比较NONMEM中一阶条件估计(FOCE)和不同期望最大化(EM)方法的性能:复杂非线性母体-代谢物药代动力学模型的真实数据经验。
J Pharmacokinet Pharmacodyn. 2021 Aug;48(4):581-595. doi: 10.1007/s10928-021-09753-0. Epub 2021 Apr 21.
6
Assessment of type I error rates for the statistical sub-model in NONMEM.NONMEM中统计子模型的I型错误率评估。
J Pharmacokinet Pharmacodyn. 2002 Jun;29(3):251-69. doi: 10.1023/a:1020254823597.
7
Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.非线性混合效应多响应模型的费希尔信息矩阵:使用药代动力学/药效学模型评估一阶线性化的适用性
Stat Med. 2009 Jun 30;28(14):1940-56. doi: 10.1002/sim.3573.
8
Evaluation of uncertainty parameters estimated by different population PK software and methods.不同群体药代动力学软件和方法所估计的不确定性参数评估。
J Pharmacokinet Pharmacodyn. 2007 Jun;34(3):289-311. doi: 10.1007/s10928-006-9046-9. Epub 2007 Jan 10.
9
Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose-response models.各种最大似然非线性混合效应估计方法在剂量反应模型中的性能比较。
AAPS J. 2012 Sep;14(3):420-32. doi: 10.1208/s12248-012-9349-2. Epub 2012 Apr 14.
10
Evaluation of the nonparametric estimation method in NONMEM VI: application to real data.NONMEM VI中非线性估计方法的评估:在实际数据中的应用
J Pharmacokinet Pharmacodyn. 2009 Aug;36(4):297-315. doi: 10.1007/s10928-009-9122-z. Epub 2009 Jul 2.

引用本文的文献

1
Comparing randomized trial designs to estimate treatment effect in rare diseases with longitudinal models: a simulation study showcased by Autosomal Recessive Cerebellar Ataxias using the SARA score.使用纵向模型比较随机试验设计以估计罕见疾病的治疗效果:一项以常染色体隐性遗传性小脑共济失调为例、采用SARA评分的模拟研究
BMC Med Res Methodol. 2025 Jul 30;25(1):179. doi: 10.1186/s12874-025-02626-x.
2
Fitting and comparison of calcium-calmodulin kinetic schemes to a common data set using non-linear mixed effects modelling.使用非线性混合效应模型将钙调蛋白动力学方案与一个通用数据集进行拟合和比较。
PLoS One. 2025 Feb 7;20(2):e0318646. doi: 10.1371/journal.pone.0318646. eCollection 2025.
3

本文引用的文献

1
Modelling of individual pharmacokinetics for computer-aided drug dosage.用于计算机辅助药物剂量计算的个体药代动力学建模。
Comput Biomed Res. 1972 Oct;5(5):411-59. doi: 10.1016/0010-4809(72)90051-1.
Effect of vaccinations and school restrictions on the spread of COVID-19 in different age groups in Germany.
疫苗接种和学校限制措施对德国不同年龄组新冠病毒传播的影响。
Infect Dis Model. 2024 Jul 24;9(4):1250-1264. doi: 10.1016/j.idm.2024.07.004. eCollection 2024 Dec.
4
Bayesian estimation in NONMEM.贝叶斯估计在 NONMEM 中的应用。
CPT Pharmacometrics Syst Pharmacol. 2024 Feb;13(2):192-207. doi: 10.1002/psp4.13088. Epub 2023 Dec 8.
5
Population pharmacokinetics of atacicept in systemic lupus erythematosus: An analysis of three clinical trials.在系统性红斑狼疮中阿托昔单抗的群体药代动力学:三项临床试验分析。
CPT Pharmacometrics Syst Pharmacol. 2023 Aug;12(8):1157-1169. doi: 10.1002/psp4.12982. Epub 2023 Jun 18.
6
Model-based assessment of combination therapies - ranking of radiosensitizing agents in oncology.基于模型的联合治疗评估 - 肿瘤学中的放射增敏剂排名。
BMC Cancer. 2023 May 6;23(1):409. doi: 10.1186/s12885-023-10899-y.
7
Model-Based Analysis of SARS-CoV-2 Infections, Hospitalization and Outcome in Germany, the Federal States and Districts.基于模型的德国、联邦州和地区 SARS-CoV-2 感染、住院和结局分析。
Viruses. 2022 Sep 24;14(10):2114. doi: 10.3390/v14102114.
8
Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against in Patients with Hospital-Acquired Pneumonia.对于医院获得性肺炎患者,联合药代动力学/药效学指数可能是头孢哌酮/舒巴坦更合适的药代动力学/药效学指数。
Antibiotics (Basel). 2022 May 23;11(5):703. doi: 10.3390/antibiotics11050703.
9
Population pharmacokinetics of roxadustat in Japanese dialysis-dependent chronic kidney disease patients with anaemia.罗沙司他在日本透析依赖性慢性肾脏病贫血患者中的群体药代动力学。
Br J Clin Pharmacol. 2022 Feb;88(2):787-797. doi: 10.1111/bcp.15023. Epub 2021 Sep 2.
10
Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models.群体数据的药物代谢动力学估算方法,包括来自其他药物代谢动力学模型模拟的数据。
J Pharmacokinet Pharmacodyn. 2021 Oct;48(5):623-638. doi: 10.1007/s10928-021-09760-1. Epub 2021 Jun 22.